CVS Health Corporation $CVS Shares Sold by Banco Bilbao Vizcaya Argentaria S.A.

Banco Bilbao Vizcaya Argentaria S.A. lessened its holdings in shares of CVS Health Corporation (NYSE:CVS) by 1.9% during the 2nd quarter, HoldingsChannel reports. The firm owned 300,340 shares of the pharmacy operator’s stock after selling 5,920 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in CVS Health were worth $20,713,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of CVS. Larson Financial Group LLC grew its stake in CVS Health by 38.2% during the 1st quarter. Larson Financial Group LLC now owns 4,126 shares of the pharmacy operator’s stock valued at $280,000 after acquiring an additional 1,141 shares in the last quarter. Bridgewater Advisors Inc. purchased a new stake in shares of CVS Health in the first quarter valued at approximately $247,000. Summit X LLC acquired a new stake in shares of CVS Health in the first quarter valued at approximately $231,000. Allen Capital Group LLC purchased a new position in CVS Health during the first quarter worth approximately $369,000. Finally, Legacy Capital Wealth Partners LLC acquired a new position in CVS Health during the first quarter worth $283,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the sale, the director owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.22% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently commented on the company. Jefferies Financial Group lifted their price target on CVS Health from $92.00 to $98.00 in a report on Thursday, October 30th. Evercore ISI lifted their target price on shares of CVS Health from $85.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 30th. The Goldman Sachs Group assumed coverage on shares of CVS Health in a research note on Tuesday, October 14th. They issued a “buy” rating and a $91.00 price target for the company. Robert W. Baird raised shares of CVS Health from a “neutral” rating to an “outperform” rating and lifted their price target for the company from $71.00 to $82.00 in a research report on Thursday, August 14th. Finally, Raymond James Financial upped their price objective on CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Two research analysts have rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $89.41.

CVS Health Price Performance

CVS stock opened at $79.32 on Friday. The business’s fifty day moving average price is $77.61 and its 200 day moving average price is $69.81. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83. The company has a market capitalization of $100.69 billion, a PE ratio of 208.74, a P/E/G ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. During the same quarter last year, the company posted $1.09 EPS. The firm’s revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, sell-side analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were given a dividend of $0.665 per share. The ex-dividend date of this dividend was Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health’s payout ratio is currently 700.00%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.